Using Inflammatory Plasma Biomarkers to Predict Preclinical Alzheimer’s Disease

Haley Leclerc, Jessica Alber, Zachary J Kunicki, Sid E O'Bryant, Athene KW Lee · 2025

Read Using Inflammatory Plasma Biomarkers to Predict Preclinical Alzheimer’s Disease by Haley Leclerc, Jessica Alber, Zachary J Kunicki, Sid E O'Bryant, Athene KW Lee (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715393.txt.

Description

Haley Leclerc and co-authors tested whether blood signs of swelling can flag silent Alzheimer's disease. Blood tests for the disease now work well once signs show. They are less sure in the stage where amyloid builds up but thought stays sharp. Swelling in the body has long been tied to the disease, so the team gave those signs a fair trial.

The group drew on one hundred twenty-five older adults with no thought loss. Each gave blood and had a brain scan for amyloid. The team ran the blood through a panel of twenty-one swelling-linked proteins, plus core disease signs. Five swelling signs sorted scan results best, but only with fair skill. Once age, schooling, sex, genes, and core signs were in the mix, the swelling signs added nothing. The core blood signs remain the ones to trust for this early stage.

Catalog record

CREATORHaley Leclerc, Jessica Alber, Zachary J Kunicki, Sid E O'Bryant, Athene KW Lee
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11715393

Browse the full library · About the Tower of Babel